News

| Chaim Friedland
December 31st, 2017

Gornitzky represents Priority Software in its acquisition of Acclivity LLC.

Gornitzky represented Priority Software in its acquisition of Acclivity LLC, a U.S. based ERP software developer for small and mid-size companies worldwide, and its affiliated LLCs.

Priority is a portfolio company of Fortissimo Capital, a prominent Israeli private equity fund and this is its fourth acquisition in recent months represented by our firm.

Priority was represented by Chaim Friedland (Partner), Sagit Amit Evan (Senior Associate), Nir Knoll (Associate).

November 13th, 2017

Gornitzky represents underwriters in RedHill Biopharma’s USD 22.5 million public offering.

Gornitzky represented the underwriters, led by Cantor Fitzgerald and Nomura Securities, in RedHill Biopharma’s USD 22.5 million underwritten public offering of American Depositary Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Cantor Fitzgerald and Nomura Securities acted as joint book-running managers for the offering. SMBC Nikko Securities acted as lead manager and H.C. Wainwright and Roth Capital acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll (Associate).

October 1st, 2017

Gornitzky represents the underwriters, led by Cowen and Company and Wells Fargo, in MediWound’s follow-on offering on NASDAQ.

Gornitzky represented the underwriters, led by Cowen and Company and Wells Fargo Securities, in the USD 25 million follow-on offering of MediWound Ltd. on the NASDAQ Global Market. MediWound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications.

 

Cowen and Company, LLC and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. Oppenheimer & Co. Inc. and SunTrust Robinson Humphrey, Inc. acted as co-lead managers for the offering. Aegis Capital Corp. acted as a co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Sagit Amit Evan (Senior Associate), together with Associates Danielle Skald and Daniella Segal.

August 13th, 2017

Gornitzky represents Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. 

Gornitzky represented Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. Since 1925, Tuttnauer has been and continues to operate as a leading manufacturer and supplier of autoclaves, washers and other sterilization applications and devices.

 

Fortissimo was represented by Chaim Friedland (Partner, Corporate/M&A), Idan Baki (Partner, Finance), Avner Finkelshtein (Partner, Antitrust), together with associates Yoav Meer, Alon Peled, Nir Knoll and Coral Leshez.

July 11th, 2017

Gornitzky represents Le Peigne in its investment in Riskified Ltd.

Gornitzky represented Le Peigne in its investment in Riskified Ltd., an Israeli startup company specializing in e-commerce fraud prevention, as part of a consortium of investors in Riskified’s USD 33 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton.


Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

May 5th, 2017

Gornitzky represents Alcobra Ltd. in blocking an attempted hostile takeover.

A private investment fund, holding a certain amount of the company's shares, called for the immediate assembly of an extraordinary general meeting of shareholders, in order to remove the existing Directors and replace them with its own. Following Alcobra's refusal, based on legal advice provided by our firm, the investment fund chose to unilaterally summon an extraordinary general meeting during the month of May. Following our appeal to the Tel Aviv District Court for Economic Affairs, an injunction was issued, prohibiting the investment fund from sending out summons and proxies to the company's shareholders in Israel and abroad. At the end of the day, the sides reached an agreement, according to which it was agreed that the extraordinary general meeting of shareholders summoned by the investment fund shall be cancelled and the company shall convene its annual general meeting on July 20, 2017.

Alcobra Ltd. was represented by Kfir Yadgar (Managing Partner), Chaim Friedland (Partner), Ari Fried (Partner), Ofer Fleischer (Partner), together with Associates Shiran Knafo and Gil Palkovic

January 17th, 2017

Gornitzky & Co. Upgrades its Technology and Hi-Tech Practice through the addition of two new partners, proven leaders in the Technology, Hi-Tech and VC fields.

Gornitzky & Co. carried out a major move through the addition of two new partners, proven leaders in the Technology, Hi-Tech and VC fields.

 

Daniel Marcus and Shlomo Landress, previously with the Tel Aviv law firm of Amit, Pollak, Matalon & Co., will head up Gornitzky & Co.'s Technology practice and expand the capacity of the firm's International team.

 

Gornitzky & Co. is one of Israel's leading law firms, with its clients consisting of some of the central players in the Israeli economy and business community. The addition of these two partners comes as part of the Firm's strategy to grow and expand its capabilities in the Technology, Hi-Tech and VC fields, and more broadly, in its cross-border activities.

 

Daniel Marcus was born in the United States and is a graduate of Columbia University in New York City. Mr. Marcus has vast experience in the areas of Hi-Tech investments, Mergers & Acquisitions, strategic collaborations and joint ventures involving major international corporations. He regularly advises founders, VC funds and start-up companies on a broad spectrum of matters, and is an expert in the areas of agreements relating to R&D, licensing, distribution, and other related commercial arrangements.

 

Shlomo Landress, who holds an LLM from NYU, focuses his practice on U.S. securities matters, and regularly advises clients on private placements, public offerings, and public reporting and filings of companies listed on the NASDAQ. Mr. Landress also advises clients in Mergers & Acquisitions, as well as representing investors and companies in early stage and VC investment transactions. Mr. Landress was formerly the general counsel to the Israel Economic Mission to North America and was an associate in the Corporate Department in the New York office of Arnold & Porter LLP.

Gornitzky & Co. is delighted to welcome these two gentlemen to its team.

 

Pinhas Rubin, the Chairman of the Firm stated: "For several years now Gornitzky & Co. has been at the forefront of the various fields of the corporate and commercial law practice, with cutting edge professional capabilities in areas such as Litigation, Tax, M&A, Capital Markets, Finance, Telecommunications, Real Estate and Energy. The Firm's clients include many of Israel's leading corporations as well as major global corporations in the activities in Israel. It is only natural that the Firm would seek to expand its capabilities in the areas of the law relevant to the international business community, and specifically, in the Technology and Hi-Tech space which is one of Israel's central growth drivers. I have no doubt that the addition of these two new partners to our Firm, will contribute to the Firm's continued growth, expansion of its client base and its position as a top rated law firm and provider of first rate legal advice in each of the legal disciplines and services in which it provides services to its clients."

 

Chaim Friedland, who heads the Firm's international practice, added: "The addition of these two partners, whose work I've admired for many years, is a major boost to our activity in the international space, which already spans several continents and a variety of disciplines, including energy, consumer products and technology. On a personal level, I am delighted that we are adding two professionals with excellent reputations in the market, both professional and personal, and I am certain that the will find a warm and welcoming home in Gornitzky, in general, in in the International Practice Group, in particular."

 

Messrs. Marcus and Landress added: "We are excited to join Gornitzky & Co. and we are certain that this superb platform will allow us to provide a broad menu of excellent services to a diverse client base, both Israeli as well as international. We are deeply grateful to our former partners and colleagues at Amit, Pollak, Matalon & Co., and we are thankful for the many wonderful years of cooperation; we wish them all the best of luck in the future."

 

Download as PDF

December 19th, 2016

Gornitzky represents Sabon Shel Pa’am and its Shareholders in the Sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group

Gornitzky represented Sabon Shel Pa’am (“Sabon”) and its Shareholders in the sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group. Sabon is a leading producer and retailer of cosmetic, body care, home style and ambience products sold in concept stores around the world. Yves Rocher is a worldwide cosmetics and beauty brand, based in La Gacilly, France. Yves Rocher is present in 88 countries on five continents

As part of the transaction, the selling shareholders will continue to hold a significant position in the global company and shall take an active role in the management of the company for the next several years, after which they shall have an exit right. In addition to negotiating the sale agreement, we were required to negotiate a shareholders agreement between Yves Rocher and the selling shareholders for the relationship between the parties and the management of the companies.

For further reading in the Marker (Hebrew)

Sabon Shel Pa’am (“Sabon”) and its Shareholders is represented by Chaim Friedland (partner), Yehonatan Raff, Yoav Meer, Sam Berkowitz, Danielle Skald (tax) and Bar Sarafian (labour)

August 30th, 2016

Gornitzky represents SeaSpine in an agreement to acquire the assets of NTL Spine, an expandable interbody platform technologies company. In the acquisition, most of NTL Spine’s assets will be transferred to SeaSpine

Gornitzky together with DLA Piper represented SeaSpine in an agreement to acquire the assets of NTL Spine, an expandable interbody platform technologies company.

In the acquisition, most of NTL Spine’s assets will be transferred to SeaSpine. NLT Spine will receive an initial payment of USD 1 million and further payments in stock conditional upon meeting milestones, and altogether, stands to receive USD 5 million in milestone payments and up to USD 43 million in royalties. NTL Spine was founded by Dr. Tzony Siegal in 2006. It is a graduate of the Incentive incubator in Ariel, and among its later investors are Accelmed and Peregrine Ventures. NLT president and CEO Didier Toubia said that the company sees SeaSpine as the ideal partner to lead NTL’s innovative solutions in the market.

 

See full story in Globes

 

SeaSpine was represented by Chaim Friedland (partner). Yoni Raff, Avi Meer and Daniel Skald

April 11th, 2016

Gornitzky & Co. is representing AHAVA shareholders in connection with the sale of 100% of AHAVA's shares to Fosun Group for an aggregate price of NIS 290 million

Gornitzky represented the shareholders of AHAVA - Dead Sea Laboratories Ltd., a manufacturer of cosmetic products composed of mineral-rich mud from the Dead Sea. Its products are sold in over 25 different countries. Gornitzky advised the shareholders in connection with the sale of 100% of the shares to the large Chinese investment conglomerate, Fosun Group, for an aggregate price of NIS 290 million. Within the framework of the agreement, Fosun will purchase the share capital of all of AHAVA’s shareholders, Gaon Holdings, the Livnat family, Shamrock Israel Growth Fund, Kibbutz Mitzpeh Shalem and Kibbutz Kalia.

 

See related article in Globes, one of Israel’s leading financial daily newspapers.

 

The shareholders were represented by Chaim Friedland (Partner, Corporate/M&A), Yoav Meer  (Corporate), Nir Knoll (Corporate), Danielle Skald (Tax), Bar Sarafian (Employment)

December 8th, 2015

Gornitzky's Chaim Friedland (Partner) was featured in "Globes" Magazine expressing his support in amending the Israeli Companies Law in such a way that will facilitate and de-regulate Dual-listed companies.

Gornitzky's Chaim Friedland (Partner) was featured in "Globes" Magazine expressing his support in amending the Israeli Companies Law in such a way that will facilitate and de-regulate Dual-listed companies - “We are on a path to a place more professional and practical. It will be less intimidating to list on Tel Aviv Stock Exchange” said adv. Friedland and added: “the important news is the new direction”.

 

See full story (Hebrew)

November 11th, 2015

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

 

Piper Jaffray & Co. acted as sole bookrunner for the offering. JMP Securities acted as lead manager and Roth Capital Partners and LifeSci Capital acted as co-managers.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

 

September 16th, 2015

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD from Tene for Investment F.E., Limited Partnership, Origo 1 Manof Fund, Limited Partnership, Origo 2 Manof Fund, Limited Partnership & Ilanit Cohen. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Fortissimo Capital Fund was represented by Chaim Friedland (Partner, Corporate/M&A), Avner Finkelshtein (Partner, Antitrust), Yehonatan RafAvi Meer, Nir Knoll and Noa Schweitzer

July 21st, 2015

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in NeuroDerm's USD 77 million follow-on offering on NASDAQ

 

 

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 77 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd., is a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases.


Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.

  

The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).

 

February 15th, 2015

Gornitzky & Co. represented the underwriters, led by Wells Fargo, in RedHill Biopharma’s USD 14.4 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market.

Gornitzky & Co. represented the underwriters, led by Wells Fargo, in RedHill Biopharma’s USD 14.4 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Wells Fargo Securities acted as lead book-running manager and Roth Capital Partners acted as joint book-running manager for the offering. MLV & Co acted as co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.


For more information on our capital markets practice, please click here.

February 4th, 2015

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. 

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton.

Taboola is a leading content discovery and marketing platform, serving over 130 billion recommendations to over 350 million unique visitors every month.

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

January 26th, 2015

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Synergy Cables Ltd. for NIS 15 million. 

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Synergy Cables Ltd. for NIS 15 million. The transaction was conducted through the Beer Sheba District Court in the context of corporate reorganization proceedings with respect to Synergy Cables and its publicly traded bonds.

Synergy Cables, headquartered in Sderot, Israel, is a global supplier of power & electrical cables.

Fortissimo Capital Fund was represented by Chaim Friedland (Partner, Corporate/M&A), Yaron Elhawi (Partner, Restructuring & Insolvency), Yair Shiloni (Partner, Capital Markets), and Avner Finkelshtein (Partner, Antitrust).

November 26th, 2014

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.  Northland Securities acted as sole underwriter for the offering.

 

Northland Capital Markets, a boutique investment banking firm that focuses on growth companies and institutional investors, was represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

October 6th, 2014

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

 

Deutsche Bank acted as book-running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

August 5th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Credit Suisse and Jefferies acted as joint book-running managers for the offering. Nomura Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

April 2nd, 2014

Gornitzky represented Altria Group Inc. in its acquisition of Green Smoke Inc., an electronic cigarette business, for USD 110 million and up to USD 20 million in incentive payments.

Gornitzky represented Altria Group Inc. (NYSE: MO) in its acquisition of Green Smoke Inc., an electronic cigarette business, and its affiliates. Altria, which owns the top U.S. cigarette maker, Philip Morris USA, has purchased Green Smoke for USD 110 million and up to USD 20 million in incentive payments.

 

Altria Group Inc. was represented by Chaim Friedland (Partner, Corporate M&A), Yoram Arad (Partner, High-Tech), Ari Fried (Partner, Corporate M&A), Idan Baki (Partner, Finance), Michael Ayalon (Partner, Labor), Dafna Michalevich-Bacharach (High-Tech), Avi Meer (Corporate) and Joanna Yanowsky (Labor).

March 5th, 2014

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.


Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

March 4th, 2014

Gornitzky & Co. represented the underwriters, led by Goldman Sachs, Credit Suisse and Jefferies, in Lumenis Ltd.’s USD 75 million public offering on the NASDAQ Global Select Market.

Gornitzky & Co. represented the underwriters, led by Goldman Sachs, Credit Suisse and Jefferies, in Lumenis Ltd.’s USD 75 million public offering on the NASDAQ Global Select Market.

 

Goldman Sachs, Credit Suisse and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities acted as co-manager for the offering.


The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.

January 16th, 2014

Gornitzky represented Shilav Group Ltd. in the sale of all of its shares in Tiny Love Ltd. and affiliated companies.

Gornitzky represented Shilav Group Ltd. in the sale of all of its shares in Tiny Love Ltd. and its U.S. and Chinese affiliates to Dorel Industries Inc. (TSX: DII/B), a Canadian corporation based in Quebec. Dorel Industries designs and manufactures for three areas: juvenile, home furnishings and recreational/leisure. The purchase price was not disclosed.

 

Tiny Love Ltd. is in the business of designing, developing and supplying retailers and distributors with activity gyms, mobiles, baby gear, baby toys and on-the-go baby toys.

 

Shilav Group Ltd. was represented by Chaim Friedland (Partner), Timor Belan (Partner), Avner Finkelshtein (Partner, Antitrust) and Yoav Meer.

August 6th, 2013

Gornitzky represented TRAX Technology Solutions Pte Ltd. in finalizing a USD 6.6 million A-round financing agreement with one of Singapore's largest private equity funds.

Gornitzky represented TRAX Technology Solutions Pte Ltd. in finalizing a USD 6.6 million A-round financing agreement with one of Singapore's largest private equity funds. The terms of the agreement include the immediate cash infusion of USD 6.6 million, with an option for an additional USD 14 million (approximately) available over the next 18 months.

 

TRAX Technology Solutions Pte Ltd. is a leading provider of in-store auditing and shelf monitoring solutions for the fast moving consumer goods industry (FMCG).

 

TRAX was represented by Chaim Friedland (Partner), Yoram Arad (Partner) and Yehonatan Raff.

 

June 4th, 2013

Gornitzky & Co. represented Starhome BV in their purchase of MACH, which is being divested by Syniverse Technologies LLC.

Gornitzky & Co. represented Starhome BV in their purchase of MACH’s data clearing and NRTRDE business within the European Economic Area, under a corporate divestiture by Syniverse Technologies LLC, as mandated and instructed by the European Commission (antitrust). The acquisition is contingent upon approval of the transaction by the European Commission and other applicable jurisdictions.

 

Starhome is a leading global provider of international roaming solutions and their products are used by more than 200 mobile operators worldwide, including by 20 of the 30 largest operators in the world. MACH is a leading provider of cloud-based managed communication services worldwide.

 

Starhome BV was represented by Chaim Friedland (Partner, Corporate/M&A), Yoram Arad (Partner, Technology/Commercial), Yisrael Spero (Partner, Corporate/M&A/Regulatory), Yehonatan Raff, Avi Meer and Ariel Davis.

April 28th, 2013

Gornitzky represented Chinese conglomerate, Fosun International Ltd., in their acquisition of Alma Lasers Ltd. for approximately USD 240 million.

Gornitzky represented Chinese conglomerate, Fosun International Ltd. (HK: 656), in all legal aspects of their approximately USD 240 million acquisition of a 95.6% stake in Alma Lasers Ltd., a manufacturer of lasers used in cosmetic surgery. Alma Lasers was purchased by Fosun International's subsidiaries, Shanghai Fosun Pharmaceuticals (Group) Co. Ltd. and Chindex Medical Ltd., and its private equity fund, Pramerica-Fosun China Opportunity Fund.

 

Fosun International is the largest private-owned (non-governmental) conglomerate in Mainland China. This is Fosun International's first acquisition since its public offering on the Hong Kong Stock Exchange and its first ever investment outside of China.

 

Fosun International Ltd. was represented by Chaim Friedland (Partner, Corporate), Gil Grady (Partner, Tax), Dubi Gross (Partner, Corporate), Avner Finkelshtein (Antitrust), Gilad Lubinsky (Litigation), Michael Ayalon (Labor), Mirit Ber-Hoffman, Yehonatan Raff, Joanna Yanowsky and Yoav Meer.

April 18th, 2013

Gornitzky represented Tene Investment Funds, a private equity firm, in the USD 168 million sale of its holdings in Caesarstone Sdot-Yam Ltd. (Nasdaq: CSTE) in an underwritten follow-on offering. 

Gornitzky represented Tene Investment Funds, a private equity firm, in the USD 168 million sale of its holdings in Caesarstone Sdot-Yam Ltd. (Nasdaq: CSTE) in an underwritten follow-on offering.

 

J.P. Morgan Securities LLC, Barclays Capital Inc. and Credit Suisse Securities (USA) LLC served as the joint bookrunning managers for the offering, and Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated served as the co-managers for the offering.

 

The representation of Tene Investment Funds was led by Chaim Friedland (Partner) and Ari Fried (Partner).

 

January 2nd, 2013

Gornitzky & Co. represented Hadas Arazim Investment House, in a merger transaction with Halman-Aldubi, subsequent to which the joint investment house will manage assets and investment in the scope of approximately USD 5 billion.

Gornitzky & Co. represented Hadas Arazim Investment House, in a merger transaction with Halman-Aldubi, subsequent to which the joint investment house will manage assets and investment in the scope of approximately USD 5 billion.

 

The transaction included the transfer and sale of shares in Hadas Arazim's subsidiaries, the merger of Hadas Arazim's provident funds management company with Halman Aldubi's provident funds management company and the refinancing of bank loans.

 

Hadas Arazim was represented by Chaim Friedland (Partner), Timor Belan (Partner) and Inbal Ravid-Badner.

November 29th, 2012

Gornitzky & Co. acted as Israeli counsel to Geni Inc., an online application for researching and building family trees based in California, in connection with its acquisition by its Israel-based rival, MyHeritage Ltd.

Gornitzky & Co. acted as Israeli counsel to Geni Inc., an online application for researching and building family trees based in California, in connection with its acquisition by its Israel-based rival, MyHeritage Ltd.

 

Gornitzky advised Geni in connection with the Israeli facets of the deal, including recommendations regarding the structure of the transaction.

 

Geni was represented by Chaim Friedland (Partner) and Yisrael Spero.

October 19th, 2012

Gornitzky & Co. represented Fortissimo Capital in their USD 80.3 million purchase of Starhome BV, a subsidiary of Comverse Technology Inc. (NASDAQ: CMVT), as well as in the financing of the transaction.

Gornitzky & Co. represented Fortissimo Capital,  in their USD 80.3 million purchase of Starhome BV, a subsidiary of Comverse Technology Inc. (NASDAQ: CMVT), as well as in the financing of the transaction.

 

In addition to legal representation of the private equity fund in the purchase and financing of the transaction, Gornitzky & Co. also negotiated a complex transitional services agreement, which provides Starhome with continued support services from Comverse.

 

Starhome is a leading provider of international roaming solutions and their products are used by more than 200 mobile operators worldwide, including by 20 of the 30 largest operators in the world. Fortissimo Capital is a group of private equity funds managing half a billion dollars.

 

Fortissimo was represented by Chaim Friedland (Partner, Corporate/M&A), Benjamin Waltuch (Partner, Corporate/M&A), Yoram Arad (Partner, Technology/Commercial), Idan Baki (Partner, Banking/Finance), Avner Finkelshtein (Antitrust), Yehonatan Raff  and Ariel Davis.

December 21st, 2011

Gornitzky represented Cabaret Security Ltd. and Arba One Inc., two of the main selling shareholders in the $40 million financing of Cyber-Ark Software Ltd.

Gornitzky represented Cabaret Security Ltd. and Arba One Inc., two of the main selling shareholders in the $40 million financing of Cyber-Ark Software Ltd.

 

The transaction involved a USD 40 million joint investment in Cyber-Ark by JVP (one of Israel's prominent VC funds) and Goldman Sachs, in a combination of a primary (issuance) and secondary (purchase from existing shareholders) stock transaction.

 

As of the closing of the financing round, Cyber-Ark's shareholders are JVP, Vertex Venture Capital, Goldman Sachs, JPMorgan Chase Partners, Cabaret Security Ltd. and Arba One Inc., Softbank Ltd. affiliate Seed Capital Partners, and Nochi Dankner-controlled IDB Development Corp. Ltd.

 

The team handling the representation included Chaim Friedland (Partner), Avner Finkelshtein and Yisrael Spero.

November 21st, 2017

Gornitzky represents Piper Jaffray in VBL Therapeutics’ USD 18.75 million follow-on offering on NASDAQ.

Gornitzky represented Piper Jaffray in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 18.75 million follow-on offering on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

Piper Jaffray & Co. acted as the sole manager for the offering.

The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).

October 30th, 2017

Gornitzky represents Apax in the acquisition of 3M’s electronic monitoring business

Gornitzky represented Apax Partners in the acquisition of 3M’s (NYSE: MMM) electronic monitoring business.

Apax was represented by Partners Chaim Friedland, Elite Elkon, Yoram Arad and Yoni Raff, and by Assaf Harel, Avi Meer, Oded Uni, Sam Berkowitz and Liron Koren. The DD team also included Dan Fisher, Ori Sheinkman (Employment), Tigist Bayleyei Salomon (Real Estate), Daniel Reshef, Daniella Segal and Sharon Reingwirtz.

For more details on the transaction see the following Apax Press Release.

August 28th, 2017

Gornitzky represents the underwriters, led by Oppenheimer & Co., in Intec Pharma’s offering.

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 57.5 million follow-on offering of Intec Pharma Ltd. on the NASDAQ Capital Market. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

 

Oppenheimer & Co. Inc. acted as sole book-running manager for the offering. Roth Capital Partners acted as lead manager, and Maxim Group LLC acted as co-manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Danielle Skald (Associate) and Nir Knoll (Associate).

August 3rd, 2017

Gornitzky represents the underwriters, led by Cantor Fitzgerald, in Kamada's follow-on offering. 

Gornitzky represented the underwriters, led by Cantor Fitzgerald, in the USD 15 million follow-on offering of Kamada Ltd. on the NASDAQ Global Select Market. Kamada is a plasma-derived protein therapeutics company focused on orphan indications, and its shares are dually traded on the NASDAQ and the Tel Aviv Stock Exchange.

Cantor Fitzgerald acted as sole book-running manager for the offering. Raymond James, Oppenheimer & Co., Ladenburg Thalmann and Chardan acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Yoav Meer (Associate), Danielle Skald (Associate) and Sharon Strauss (Associate).

May 11th, 2017

Gornitzky represented the underwriters, led by Jefferies and Cowen & Company, in the USD 67 million IPO of UroGen Pharma Ltd. on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Jefferies and Cowen & Company, in the USD 67 million IPO of UroGen Pharma Ltd. on the NASDAQ Global Market. UroGen Pharma is a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology.

 

The IPO was the first major underwritten IPO of an Israeli company in the United States since 2015.

 

Jefferies and Cowen & Company acted as joint book-running managers for the offering. Raymond James & Associates and Oppenheimer & Co. acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan (Associate).

 

April 5th, 2017

Gornitzky represents Mobile operator Golan Telecom, which was acquired by Electra Consumer Products (ECP) for NIS 350 million.

Upon receiving all necessary regulatory approvals, the acquisition of Golan Telecom by ECP for NIS 350 million has been completed. The deal was signed at the start of January 2017, and upon completion of ECP's due diligence and receipt of all regulatory approvals, the deal was consummated with ECP acquiring control of Golan Telecom.


Golan Telecom and its shareholders were represented by Chaim Friedland (Partner, Corporate), Lior Porat (Partner, Telecoms), Avner Finkelshtein (Partner, Antitrust), together with Avi Meer, Asaf Avtuvi and Noa Schweitzer.

 

December 27th, 2016

Gornitzky represents the underwriters, led by Roth Capital, in RedHill Biopharma’s USD 39 million public offering and concurrent registered direct offering of its ADSs and warrants

Gornitzky represented the underwriters, led by Roth Capital Partners, in RedHill Biopharma’s USD 39 million underwritten public offering of American Depositary Shares (ADSs) and warrants on the NASDAQ Capital Market and concurrent registered direct offering of its ADSs and warrants. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases and cancer, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

Roth Capital Partners acted as the sole book-running manager and Echelon Wealth Partners acted as Canadian manager for the underwritten public offering with respect to sales in Canada. Roth Capital Partners acted as placement agent in the registered direct offering.

 

See full story

The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).

December 12th, 2016

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 86 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 86 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd. is a clinical stage pharmaceutical company developing treatments for central nervous system (CNS) disorders.

Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll.

August 17th, 2016

Gornitzky represents the American car manufacturing Ford in in a multi-million dollar acquisition of SAIPS, an Israeli computer vision and machine learning company. 

Gornitzky represented the American car manufacturing Ford in connection with the acquisition of SAIPS, an Israeli computer vision and machine learning company. Ford announced the acquisition as part of its pledge to develop a commercial fully autonomous vehicle fleet by 2021.

 

See full story in Globes

 

Ford was represented by Chaim Friedland (Partner) Daniel Paserman (Partner, Tax), Yehonatan Raff, Aviad Rabinowitz, Danielle Skald (Tax) and Bar Sarafian.

March 31st, 2016

Yet another successful year and recognition of our outstanding abilities! This year, as in previous years, Chambers and Partners, top ranked our firm in various categories. 

Yet another successful year and recognition of our outstanding abilities! This year, as in previous years, the esteemed international ranking guide, Chambers and Partners, top ranked our firm in various categories. Among those prominently ranked were the Head of the Firm, Adv. Pinhas Rubin, who was ranked Eminent Practitioner in the field of Banking and Mergers and Acquisitions, as well as Band 1 in the field of Tax and Litigation; Adv. Jack Smith (Partner) was ranked Band 1 in the field of Energy and Adv. Chaim Friedland (Partner) was ranked Band 1 in the field of Capital Markets. Additional partners, defined as leaders in their field are Eyal Marom and Shlomo Cohen in Real Estate, Ofer Tzur in Litigation, Itay Geffen in Capital Markets and Infrastructure and Project Finance, Elite Elkon, Eli Elya and Dubi Gross in Banking and Finance, Daniel Paserman and Gil Grady in Tax and Avner Finkelshtein in Antitrust

November 18th, 2015

Gornitzky represented the underwriters, led by Jefferies and Barclays, in Alcobra Ltd.’s USD 40 million offering of shares on the NASDAQ Global Market. 

Gornitzky represented the underwriters, led by Jefferies and Barclays, in Alcobra Ltd.’s USD 40 million offering of shares on the NASDAQ Global Market. Alcobra is an emerging pharmaceutical company primarily focused on the development and commercialization of a proprietary drug candidate, MDX, to treat cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X

Syndrome (FXS).

 

Jefferies and Barclays acted as joint book-running managers for the offering. Oppenheimer, Roth Capital and Cantor Fitzgerald acted as co-managers for the offering

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Avi Meer.

October 21st, 2015

Gornitzky represented Lumen Capital controlled by the Weil family in its successful bid for and acquisition of the "Nesher" cement production facility in Hartuv, Israel

Gornitzky represented Lumen Capital controlled by the Weil family in its successful bid for and acquisition of the "Nesher" cement production facility in Hartuv, Israel. The sale of this facility by Nesher Israel Cement Enterprises Ltd. was carried out pursuant to the divestiture order of the Israeli Antitrust Commissioner. As a result of this transaction the cement production market has been opened to competition after a period of 67 years of being subject to a complete and exclusive monopoly held by Nesher.

The Gornitzky team was led by Partners Itay Geffen (Corporate, Infrastructure & Project Finance), Chaim Friedland (Corporate, Mergers & Acquisitions), Avner Finkelshtein (Antitrust) and associate Yael Kleinman.

July 22nd, 2015

Gornitzky represents the underwriters, led by Nomura and Roth Capital, in RedHill Biopharma’s USD 40 million public offering of ADSs

 

 

 

 

 

Gornitzky represented the underwriters, led by Nomura and Roth Capital Partners, in RedHill Biopharma’s USD 40 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Nomura Securities and Roth Capital Partners acted as joint book-running managers for the offering. MLV & Co. and H.C. Wainwright acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.

 

 

March 25th, 2015

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. 

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. SteadyMed is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs.

Wells Fargo Securities and RBC Capital Markets acted as joint book-running managers for the offering. JMP Securities acted as lead manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

February 9th, 2015

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

 

3D Systems Corporation, a market leader in 3D printing, was represented by Chaim Friedland (Partner), Assaf Harel, Yehontan Raff, Danielle Skald (Tax), Bar Sarafian (Labor Law) and Ben Goldman.

February 2nd, 2015

Gornitzky represented Fortissimo in its acquisition of a group of companies, including Enercon Ariel Ltd.

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of a group of companies, including Enercon Ariel Ltd. The companies develop, produce and market power supply and UPS systems, which are used by leading manufacturers of aviation, aerospace, naval and ground military/defense equipment, as well as for civilian use. The purchase amount is undisclosed.

 

Enercon Ariel Ltd. is a leading designer/manufacturer of custom power supplies for the aerospace and defense industries.

 

Fortissimo Capital Fund was represented by Chaim Friedland (Partner), Timor Belan (Partner), Avner Finkelshtein (Partner, Antitrust), Michael Ayalon (Partner, Labor Law), Idan Baki (Partner, Finance), Shira Porat (Finance), Lior Grinblat, and Ariel Davis.   

January 15th, 2015

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. 

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton. 

 

Moovit is a mobile application that enables users to track information on public transport. 

 

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

November 19th, 2014

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 45 million initial public offering of NeuroDerm Ltd. on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 45 million initial public offering of NeuroDerm Ltd. on the NASDAQ Global Market.


Jefferies and Cowen and Company acted as joint book-running managers for the offering. Oppenheimer & Co. and Roth Capital Partners acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yehonatan Raff.

August 31st, 2014

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix.

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix USA Corp., a developer of 3D virtual reality simulation systems for training doctors to conduct complex surgical and treatment procedures.

 

3D Systems Inc. (NYSE: DDD) was represented by Chaim Friedland (Partner), Daniel Paserman (Partner, Tax), Avi Meer and Danielle Skald.

May 5th, 2014

Chaim Friedland, a partner at Gornitzky & Co., was featured in an article in The American Lawyer magazine on the rising business activity in Israel's financial markets.

Chaim Friedland, a partner at Gornitzky & Co., was featured in an article in The American Lawyer magazine on the rising business activity in Israel's financial markets and the growing number of Israeli companies listed outside Israel.

 

Mr. Friedland attributes the growth to the fact that, "The companies that are coming out of Israel are highly innovative and cater to global markets.  They have outgrown the size of the Israeli stock exchange." Mr. Friedland believes that Israeli companies' natural affinity for US stock markets creates an opportunity to raise US investors' awareness of Israeli companies.  This, together with the inviting Israeli regulations for foreign investors, has had a major hand in the economic turnaround Israel has witnessed over the last year.

March 26th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.


Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.

 

Credit Suisse, Jefferies and BMO Capital Markets acted as joint book-running managers for the offering. Oppenheimer & Co. acted as co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

March 5th, 2014

Gornitzky & Co. represented the underwriters, led by Jefferies, in Compugen Ltd.’s USD 72.5 million public offering on the NASDAQ Global Market.


Gornitzky & Co. represented the underwriters, led by Jefferies, in Compugen Ltd.’s USD 72.5 million public offering on the NASDAQ Global Market. Compugen is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: CGEN, TASE: CGEN).

 

Jefferies LLC acted as the sole bookrunner for the offering.  JMP Securities, Oppenheimer & Co. and Chardan Capital Markets acted as co-managers.


The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Ariel Davis.

February 2nd, 2014

Gornitzky & Co. represented Fortissimo Capital Fund in its NIS 192 million acquisition of Eshbel Technologies Ltd., after receiving court approval for the transaction.

Gornitzky & Co. represented Fortissimo Capital Fund in its NIS 192 million acquisition of Eshbel Technologies Ltd. The transaction was conducted through the Central Region District Court in the context of insolvency proceedings with respect to Eshbel.

 

Eshbel is the developer of Priority, proprietary ERP software for small and medium businesses worldwide.

 

Fortissimo Capital Fund was represented by Chaim Friedland (Partner, Corporate/M&A), Maya Sabari (Sadeh) (Partner, Litigation), Idan Baki (Partner, Finance), Avner Finkelshtein (Partner, Antitrust) and Ariel Davis.

October 3rd, 2013

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering. Wells Fargo Securities, LLC acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

June 5th, 2013

Gornitzky & Co. represented the underwriters led by Morgan Stanley and Jefferies in the USD 59 million initial public offering of Kamada Ltd. on NASDAQ.

Gornitzky & Co. represented the underwriters, led by Morgan Stanley and Jefferies, in the USD 59 million initial public offering of Kamada Ltd. on the NASDAQ Global Select Market.

 

Kamada, a biopharmaceutical company engaged in specialty life-saving therapeutics, was traded on the Tel Aviv Stock Exchange prior to the NASDAQ offering and its shares are now traded on both the TASE and NASDAQ.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

May 8th, 2013

Gornitzky represented an international consortium of investors in the acquisition of a controlling stake in Carmel Winery, valued at NIS 130 million.

Gornitzky represented an international consortium of investors in the acquisition of a controlling stake in Carmel Winery. The winery, valued at NIS 130 million, is Israel’s oldest and largest commercial winery, founded in 1882 by Baron Edmond de Rothschild.

 

The purchasing consortium was organized by Kedma Capital, a private equity fund, and is comprised of both Israeli and foreign investors, including the Jesselson family.

The investors were represented by Chaim Friedland (Partner), Yisrael Spero (Partner), Avner Finkelshtein and Yoav Meer.

April 24th, 2013

Gornitzky advised Prolor Biotech Inc. in their merger with Opko Health Inc., under which Opko will acquire Prolor in a stock-for-stock merger valued at approximately USD 480 million.

Gornitzky advised Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH) in connection with their proposed merger with Opko Health Inc. (NYSE: OPK). Under the merger agreement, Opko will acquire Prolor for USD 480 million in shares, one third more than its market cap of approximately USD 370 million. The merger is subject to various conditions, including stockholder approval and regulatory approvals.

 

Prolor Biotech Inc., a biopharmaceutical company focused on developing and commercializing longer-acting proprietary versions of already approved therapeutic proteins, was represented by Chaim Friedland (Partner, Corporate), Gil Grady (Partner, Tax), Dubi Gross (Partner, Corporate), Avner Finkelshtein (Antitrust), Yehonatan Raff and Ariel Davis.

January 15th, 2013

Gornitzky & Co. represented Mustang Mezzanine Fund in connection with a mezzanine loan to Malka Retail Group Ltd., a privately-held company and a dominant middle-size fashion manufacturer and retailer, with leading brands such as “ML” and “Jump”.

Gornitzky & Co. represented Mustang Mezzanine Fund in connection with a mezzanine loan to Malka Retail Group Ltd., a privately-held company, and a dominant middle-size fashion manufacturer and retailer, with leading brands such as “ML” and “Jump”. The transaction with Mustang is directed towards funding the future non-organic growth of the group.

 

Mustang Mezzanine Fund was represented by Mr. Chaim Friedland (Partner), Mr. Yair Shiloni (Partner), Mr. Yiftah Farber and Mr. Yoav Meer.

December 10th, 2012

Gornitzky & Co. represented a group of investors in their investment in iMingle Ltd., an online Facebook application.

Gornitzky & Co. represented a group of investors in their investment in iMingle Ltd., an online Facebook application.

 

iMingle is the leading online live party and events application on Facebook, with over 6.5 million registered users.

 

The investors were represented by Chaim Friedland (Partner) and Yehonatan Raff.

 

November 19th, 2012

Gornitzky represented Israel Corporation Ltd. and entities controlled by the Ofer Group in connection with a convertible note financing in Better Place Inc. of up to an aggregate of USD 100 million.

Gornitzky represented Israel Corporation Ltd. and entities controlled by the Ofer Group in connection with a convertible note financing in Better Place Inc. of up to an aggregate of USD 100 million.

 

The investment was made by existing shareholders of Better Place and included, in addition to Israel Corporation and the entities controlled by the Ofer Group, additional shareholders of Better Place, including a leading global financial institution.

 

Zvi Ephrat (Senior Partner), Chaim Friedland (Partner) and Avishai Marom led the representation.

August 2nd, 2012

Triveni Engineering & Industries, a publicly traded industrial group based in India, was recently represented by Gornitzky & Co. in their strategic investment in Aqwise, an Israeli water and wastewater treatment solutions company.

Triveni Engineering & Industries, a publicly traded industrial group based in India, with a fast growing water division focused on high-end technology projects, was represented by Gornitzky & Co. in their strategic investment in Aqwise, an Israeli water and wastewater treatment solutions company.

 

The agreement between the investor and the company calls for commercial cooperation between the two, and included two share purchases – a primary issuance from Aqwise to Triveni, as well as a secondary purchase of a portion of shares from existing shareholders.

 

The representation was led by Mr. Chaim Friedland (Partner), Mr. Yisrael Spero and Mr. Ariel Davis.

 

September 22nd, 2011

Gornitzky & Co. represented the underwriters, led by JPMorgan, Credit Suisse and Barclays, in the secondary public offering of Mellanox Technologies Ltd. on the NASDAQ.

Gornitzky & Co. represented the underwriters, led by JPMorgan, Credit Suisse and Barclays, in the secondary public offering of Mellanox Technologies Ltd. on the NASDAQ.

 

Mellanox Technologies Ltd., dually traded on the NASDAQ and the Tel Aviv Stock Exchange, conducted a secondary public offering of its shares on the NASDAQ in September 2011. The underwriters, led by JPMorgan, Credit Suisse and Barclays, were represented by Gornitzky & Co. and White & Case, LLP. The aggregate net proceeds from the offering were approximately USD 105 million, making it the second largest SPO of an Israeli company on the NASDAQ in 2011.

 

Gornitzky's representation of the underwriters was led by Mr. Chaim Friedland (Partner) and Mr. Ari Fried (Partner).